JP2007500706A5 - - Google Patents

Download PDF

Info

Publication number
JP2007500706A5
JP2007500706A5 JP2006522022A JP2006522022A JP2007500706A5 JP 2007500706 A5 JP2007500706 A5 JP 2007500706A5 JP 2006522022 A JP2006522022 A JP 2006522022A JP 2006522022 A JP2006522022 A JP 2006522022A JP 2007500706 A5 JP2007500706 A5 JP 2007500706A5
Authority
JP
Japan
Prior art keywords
alkyl
ethyl
group
yloxy
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006522022A
Other languages
English (en)
Japanese (ja)
Other versions
JP4726238B2 (ja
JP2007500706A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/024309 external-priority patent/WO2005012297A1/en
Publication of JP2007500706A publication Critical patent/JP2007500706A/ja
Publication of JP2007500706A5 publication Critical patent/JP2007500706A5/ja
Application granted granted Critical
Publication of JP4726238B2 publication Critical patent/JP4726238B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006522022A 2003-07-28 2004-07-27 ベンズイミダゾール、ベンズチアゾールおよびベンゾキサゾール誘導体およびlta4hモジュレーターとしてのそれらの使用 Expired - Fee Related JP4726238B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49071003P 2003-07-28 2003-07-28
US60/490,710 2003-07-28
PCT/US2004/024309 WO2005012297A1 (en) 2003-07-28 2004-07-27 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators

Publications (3)

Publication Number Publication Date
JP2007500706A JP2007500706A (ja) 2007-01-18
JP2007500706A5 true JP2007500706A5 (enExample) 2007-09-20
JP4726238B2 JP4726238B2 (ja) 2011-07-20

Family

ID=34115427

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006521973A Pending JP2007500703A (ja) 2003-07-28 2004-07-27 ベンズイミダゾール、ベンズチアゾールおよびベンゾキサゾール誘導体およびlta4hモジュレーターとしてのそれらの使用
JP2006522022A Expired - Fee Related JP4726238B2 (ja) 2003-07-28 2004-07-27 ベンズイミダゾール、ベンズチアゾールおよびベンゾキサゾール誘導体およびlta4hモジュレーターとしてのそれらの使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2006521973A Pending JP2007500703A (ja) 2003-07-28 2004-07-27 ベンズイミダゾール、ベンズチアゾールおよびベンゾキサゾール誘導体およびlta4hモジュレーターとしてのそれらの使用

Country Status (28)

Country Link
US (2) US20050043378A1 (enExample)
EP (2) EP1660492B1 (enExample)
JP (2) JP2007500703A (enExample)
KR (2) KR20060054408A (enExample)
CN (2) CN1856490A (enExample)
AR (2) AR045730A1 (enExample)
AT (2) ATE403654T1 (enExample)
AU (2) AU2004261610B2 (enExample)
BR (2) BRPI0413072A (enExample)
CA (2) CA2534212A1 (enExample)
CY (1) CY1108560T1 (enExample)
DE (2) DE602004016002D1 (enExample)
DK (2) DK1660491T3 (enExample)
ES (2) ES2313079T3 (enExample)
HR (2) HRP20060039A2 (enExample)
IL (1) IL173372A (enExample)
MY (1) MY145080A (enExample)
NO (2) NO20060771L (enExample)
NZ (2) NZ544938A (enExample)
PL (2) PL1660491T3 (enExample)
PT (2) PT1660491E (enExample)
RU (2) RU2359970C2 (enExample)
SG (2) SG129449A1 (enExample)
SI (2) SI1660492T1 (enExample)
TW (2) TWI362383B (enExample)
UA (2) UA82888C2 (enExample)
WO (2) WO2005012296A1 (enExample)
ZA (2) ZA200601720B (enExample)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060054408A (ko) * 2003-07-28 2006-05-22 얀센 파마슈티카 엔.브이. 벤즈이미다졸, 벤즈티아졸 및 벤즈옥사졸 유도체 및lta4 h 조정자로서의 그의 용도
KR20080003385A (ko) * 2005-03-31 2008-01-07 얀센 파마슈티카 엔.브이. 페닐 및 피리딜 lta4h 조절제
EP1877379B1 (en) 2005-04-13 2013-01-16 Astex Therapeutics Limited Hydroxybenzamide derivatives and their use as inhibitors of hsp90
EP1717235A3 (en) * 2005-04-29 2007-02-28 Bioprojet Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands
BRPI0615449A2 (pt) * 2005-09-02 2011-05-17 Hoffmann La Roche compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem, método de tratamento e/ou prevenção de enfermidades que estão associadas com a modulação de receptores de sst do subtipo 5 e uso desses compostos
JP5133889B2 (ja) 2005-09-21 2013-01-30 デコード ジェネティクス イーエイチエフ 炎症治療のためのビアリール基置換複素環lta4h阻害剤
US7576102B2 (en) 2005-12-21 2009-08-18 Decode Genetics Ehf Biaryl substituted nitrogen containing heterocycle inhibitors of LTA4H for treating inflammation
AU2006327243A1 (en) 2005-12-21 2007-06-28 Decode Genetics Ehf N-linked aryl heteroaryl inhibitors of LTA4H for treating inflammation
EP1968961A2 (en) * 2005-12-21 2008-09-17 Decode Genetics EHF Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation
EP3205644A1 (en) 2005-12-29 2017-08-16 Celtaxsys Inc. Diamine derivatives as inhibitors of leukotriene a4 hydrolase
JP2009525269A (ja) * 2006-01-30 2009-07-09 ユーロ−セルティーク エス.エイ. カルシウムチャネルブロッカーとしての環状尿素化合物
US7754725B2 (en) 2006-03-01 2010-07-13 Astex Therapeutics Ltd. Dihydroxyphenyl isoindolymethanones
US7951829B2 (en) * 2006-05-03 2011-05-31 Janssen Pharmaceutica Nv Benzimidazole modulators of VR1
HRP20110412T1 (hr) * 2006-06-16 2011-06-30 H. Lundbeck A/S Kristalni oblici 4-[2-4-(4-metilfenilsulfanil)fenil]piperidina sa kombiniranom inhibicijom reapsorpcije serotonina i norepinefrina za liječenje neuropatskih bolova
WO2008019284A1 (en) * 2006-08-04 2008-02-14 Decode Genetics Ehf Phenoxymethylalkyne inhibitors of lta4h for treating inflammation
US8115005B2 (en) 2006-08-04 2012-02-14 Decode Genetics Ehf. Pyrazolylphenyl and pyrrolylphenyl inhibitors of LTA4H for treating inflammation
WO2008019306A2 (en) * 2006-08-04 2008-02-14 Decode Genetics Ehf Aryl amino acid derivatives as inhibitors of lta4h (leukotriene a4 hydrolase) for treating inflammation
US9730912B2 (en) 2006-10-12 2017-08-15 Astex Therapeutics Limited Pharmaceutical compounds
US8883790B2 (en) 2006-10-12 2014-11-11 Astex Therapeutics Limited Pharmaceutical combinations
GB0620259D0 (en) 2006-10-12 2006-11-22 Astex Therapeutics Ltd Pharmaceutical compounds
US8277807B2 (en) 2006-10-12 2012-10-02 Astex Therapeutics Limited Pharmaceutical combinations
EP2073803B1 (en) 2006-10-12 2018-09-19 Astex Therapeutics Limited Pharmaceutical combinations
TW200906396A (en) * 2007-02-14 2009-02-16 Janssen Pharmaceutica Nv LTA4H modulators and uses thereof
AU2008222812B2 (en) * 2007-03-08 2012-03-22 Irm Llc Compounds and compositions as modulators of GPR119 activity
JPWO2008120710A1 (ja) * 2007-03-30 2010-07-15 パナソニック電工株式会社 活動強度計
PE20091017A1 (es) * 2007-10-31 2009-07-16 Janssen Pharmaceutica Nv Diaminas en puente o fusionadas sustituidas con arilo como moduladores de leucotrieno a4 hidrolasa
KR101585848B1 (ko) * 2007-11-16 2016-01-15 애브비 인코포레이티드 관절염의 치료 방법
KR101228378B1 (ko) * 2008-04-11 2013-01-31 얀센 파마슈티카 엔.브이. 류코트리엔 α4 하이드롤레이즈의 조정제로서의 티아졸로피리딘-2-일옥시-페닐 및 티아졸로피라진-2-일옥시-페닐 아민
GB0806527D0 (en) 2008-04-11 2008-05-14 Astex Therapeutics Ltd Pharmaceutical compounds
SI2294066T1 (sl) 2008-04-28 2014-12-31 Janssen Pharmaceutica N.V. Benzoimidazoli kot inhibitorji prolil-hidroksilaze
NZ596137A (en) * 2009-05-14 2013-08-30 Janssen Pharmaceutica Nv Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene a4 hydrolase
CN102442961A (zh) * 2010-11-10 2012-05-09 江苏德峰药业有限公司 1-甲基四氮唑的生产方法
CN102442962A (zh) * 2010-11-10 2012-05-09 江苏德峰药业有限公司 1-烷基四氮唑的生产方法
EP2776023B1 (en) 2011-10-25 2016-03-09 Janssen Pharmaceutica, N.V. Meglumine salt formulations of 1-(5,6-dichloro-1h-benzo[d]imidazol-2-yl)-1h-pyrazole-4-carboxylic acid
WO2014164658A1 (en) 2013-03-12 2014-10-09 Celtaxsys, Inc. Methods of inhibiting leukotriene a4 hydrolase
CA2906086A1 (en) 2013-03-14 2014-09-25 Celtaxsys, Inc. Inhibitors of leukotriene a4 hydrolase
EP2968264A4 (en) 2013-03-14 2016-11-02 Celtaxsys Inc INHIBITORS OF LEUCOTRIENE A4 HYDROLASE
CA2906084A1 (en) 2013-03-14 2014-09-25 Celtaxsys, Inc. Inhibitors of leukotriene a4 hydrolase
RS56615B1 (sr) * 2013-12-17 2018-02-28 Lilly Co Eli Derivati fenoksietil cikličnih amina i njihova aktivnost kao modulatora ep4 receptora
EP3233077A4 (en) 2014-12-19 2018-08-08 The Broad Institute Inc. Dopamine d2 receptor ligands
EP3233799B1 (en) 2014-12-19 2021-05-19 The Broad Institute, Inc. Dopamine d2 receptor ligands
HRP20200064T1 (hr) 2015-06-09 2020-04-03 Abbvie Inc. Modulatori nuklearnih receptora (ror) namijenjeni liječenju upalnih i autoimunih bolesti
JP6931058B2 (ja) 2016-12-21 2021-09-01 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 抗体のインビトロ糖鎖工学における酵素の再使用
MX2019006123A (es) 2016-12-21 2019-08-12 Hoffmann La Roche Metodo para glicomanipulacion in vitro de anticuerpos.
CN107663192B (zh) * 2017-11-03 2019-05-10 梯尔希(南京)药物研发有限公司 一种雷贝拉唑杂质的制备方法
ES3014615T3 (en) 2018-05-31 2025-04-23 Celltaxis Llc Method of reducing pulmonary exacerbations in respiratory disease patients
WO2020087031A1 (en) 2018-10-26 2020-04-30 The Research Foundation For The State University Of New York Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia
CA3126021A1 (en) * 2019-01-11 2020-07-16 Naegis Pharmaceuticals Inc. Leukotriene synthesis inhibitors
CN110026557B (zh) * 2019-05-28 2021-08-27 南方科技大学 一种混合固体颗粒重熔的直写装置及成型方法
AU2021383768A1 (en) * 2020-11-19 2023-06-29 Telo Therapeutics, Inc. Small molecule compounds and compositions
US11932630B2 (en) * 2021-04-16 2024-03-19 Novartis Ag Heteroaryl aminopropanol derivatives
CN113683491A (zh) * 2021-09-01 2021-11-23 王传良 一种4-(2-溴乙基)苯酚的制备方法
CN113735798B (zh) * 2021-09-27 2022-07-12 安徽美致诚药业有限公司 一种盐酸罗沙替丁醋酸酯的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873346A (en) * 1985-09-20 1989-10-10 The Upjohn Company Substituted benzothiazoles, benzimidazoles, and benzoxazoles
CA1319144C (en) * 1986-11-14 1993-06-15 Quirico Branca Tetrahydronaphthalene derivatives
IL90337A0 (en) * 1988-05-24 1989-12-15 Pfizer Aromatic and heterocyclic carboxamide derivatives as antineoplastic agents
IT1240598B (it) * 1990-03-13 1993-12-17 Mini Ricerca Scient Tecnolog Derivati amminici ad azione antifungina
US5585492A (en) * 1994-10-11 1996-12-17 G. D. Searle & Co. LTA4 Hydrolase inhibitors
US5889006A (en) * 1995-02-23 1999-03-30 Schering Corporation Muscarinic antagonists
IL117149A0 (en) * 1995-02-23 1996-06-18 Schering Corp Muscarinic antagonists
US5925654A (en) * 1997-03-12 1999-07-20 G.D. Searle & Co. LTA4 , hydrolase inhibitors
EA200000873A1 (ru) * 1998-02-25 2001-04-23 Дженетикс Инститьют, Инк. Ингибиторы фосфолипазы a
US6514964B1 (en) * 1999-09-27 2003-02-04 Amgen Inc. Fused cycloheptane and fused azacycloheptane compounds and their methods of use
US20040110757A1 (en) * 2002-03-21 2004-06-10 Thomas Arrhenius Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
KR20060054408A (ko) * 2003-07-28 2006-05-22 얀센 파마슈티카 엔.브이. 벤즈이미다졸, 벤즈티아졸 및 벤즈옥사졸 유도체 및lta4 h 조정자로서의 그의 용도
US7541466B2 (en) * 2003-12-23 2009-06-02 Genzyme Corporation Tetrahydroisoquinoline derivatives for treating protein trafficking diseases
CA2595791C (en) * 2005-03-16 2013-10-08 Meda Pharma Gmbh & Co. Kg The combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases
TW200906396A (en) * 2007-02-14 2009-02-16 Janssen Pharmaceutica Nv LTA4H modulators and uses thereof

Similar Documents

Publication Publication Date Title
JP2007500706A5 (enExample)
CA2534228A1 (en) Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators
JP2007500703A5 (enExample)
JP6339595B2 (ja) 炎症性障害の治療のための化合物及びその医薬組成物
DE60017179T2 (de) Tyrosin kinaseinhibitoren
JP2009523816A (ja) 2−イミノ−ベンズイミダゾール類
JP2008520741A5 (enExample)
JP2006503010A5 (enExample)
US10189826B2 (en) Heterocyclic compounds and methods of use
JP2020531498A5 (enExample)
JP2021506889A5 (enExample)
JP2007523182A5 (enExample)
CN1152870A (zh) 杂环化合物作为多巴胺d3配位体的用途
JP2010510224A (ja) ケモカイン受容体拮抗薬としてのアミノピロリジン類
KR20180099933A (ko) 복소환 아민 및 이의 용도
JP2020516671A5 (enExample)
JP2007507511A5 (enExample)
PT1581532E (pt) Compostos pirazolo[3,4-b]piridina e seu uso como inibidores de fosfodiesterase
JP2006524254A5 (enExample)
RU2015129538A (ru) Замещенные имидазопиридины в качестве ингибиторов hdm2
JP2018534328A5 (enExample)
JP2009536196A5 (enExample)
JP2004528304A5 (enExample)
CA2605899A1 (en) Triazole derivatives as vasopressin antagonists
JP2020520354A5 (enExample)